Appropriate surveillance for late complications in patients in remission from hodgkin lymphoma

Deborah L. Darrington, Julie M. Vose

Research output: Contribution to journalReview article

Abstract

Once considered to be incurable, now most patients with the diagnosis of Hodgkin lymphoma (HL) survive and are cured of their disease. Although HL survivors are out living their disease, they continue to have increased morbidity and mortality compared to their age-matched and sex-matched peers in the general population. Late complications of their treatment are well documented and include cardiovascular diseases, pulmonary diseases, endocrine dysfunction and second malignancy. Research exploring appropriate surveillance for these complications is lacking. However, evidence to support surveillance is mounting and many are publishing consensus-based guidelines recommending surveillance for these anticipated complications. This review will summarize the most recent literature addressing the appropriate surveillance for late complications in patients in remission from HL.

Original languageEnglish (US)
Pages (from-to)200-207
Number of pages8
JournalCurrent Hematologic Malignancy Reports
Volume7
Issue number3
DOIs
StatePublished - Sep 1 2012

Keywords

  • Complications
  • Hodgkin disease
  • Hodgkin lymphoma
  • Late effects
  • Surveillance
  • Survivors

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Appropriate surveillance for late complications in patients in remission from hodgkin lymphoma'. Together they form a unique fingerprint.

  • Cite this